About Molecule.one
Molecule.one is a company based in Warsaw (Poland) founded in 2016 by Pawel Wodarczyk Pruszynski, Piotr Byrski, and Pawel Laskarzewski. Molecule.one has raised $4.63 million across 2 funding rounds from investors including Atmos Ventures, AME Cloud Ventures and Cherubic Ventures. Molecule.one offers products and services including Custom Synthesis, SpaceM1, M1 RetroScore, Data Generation & Licensing, and MariaAI. Molecule.one operates in a competitive market with competitors including Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others.
- Headquarter Warsaw, Poland
- Founders Pawel Wodarczyk Pruszynski, Piotr Byrski, Pawel Laskarzewski
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molecule One Sp. Z O.O.
-
Annual Revenue
$239.18 K (USD)212as on Dec 31, 2022
-
Net Profit
-$1.31 M (USD)-122as on Dec 31, 2022
-
EBITDA
-$1.23 M (USD)-123as on Dec 31, 2022
-
Total Equity Funding
$4.63 M (USD)
in 2 rounds
-
Latest Funding Round
$4.63 M (USD), Seed
May 04, 2021
-
Investors
Atmos Ventures
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecule.one
Molecule.one offers a comprehensive portfolio of products and services, including Custom Synthesis, SpaceM1, M1 RetroScore, Data Generation & Licensing, and MariaAI.
Reliable service for synthesizing compounds tailored to client needs.
Platform for accessing over 1 trillion drug-like molecules for synthesis.
AI tool to predict synthetic accessibility of novel molecules.
Custom dataset creation for chemistry problem-solving.
Internal agent for automating molecular synthesis processes.
People of Molecule.one
Unlock access to complete
Funding Insights of Molecule.one
Molecule.one has successfully raised a total of $4.63M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4.63 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Molecule.one
Molecule.one has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Atmos Ventures, AME Cloud Ventures and Cherubic Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
AME Cloud Ventures is focused on investing in data-driven technology companies.
|
Locked | Locked | Locked | |
|
Seed-stage technology startups are invested in by Cherubic Ventures.
|
Locked | Locked | Locked |
Investor details for Molecule.one
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecule.one
Investment portfolio details for Molecule.one
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecule.one
Detailed financials for Molecule.one
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecule.One Comparisons
Peer comparison for Molecule.one
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecule.one
Molecule.one operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Provider of a platform for in silico drug discovery and consulting services
|
|
| Locked | Locked | Locked |
Developer of a platform for protein function analysis
|
|
| Locked | Locked | Locked |
Immune system-based drugs are discovered via biological data analytics.
|
|
| Locked | Locked | Locked |
Synthetic biology tools are developed via genetic code recoding techniques.
|
|
| Locked | Locked | Locked |
Provider of AI-based solutions for materials informatics
|
Detailed competitors of Molecule.one
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecule.One
Complete news archive for Molecule.one
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecule.one
Molecule.one was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Molecule.one is headquartered in Warsaw, Poland.
Piotr Byrski is the current CEO of Molecule.one. They have also founded this company.
Molecule.one is a funded company, having raised a total of $4.63M across 2 funding rounds to date.
Annual revenue of Molecule.one is $239.18K as on Dec 31, 2022.
Founded in 2016 and based in Warsaw, Poland, Molecule.one operates in the biotechnology sector. AI-driven software is developed to assist in molecule drug designing and synthesis. Search criteria are selected by users, after which relevant reactions are proposed, scored for viability, and assembled into complete synthesis pathways. This technology supports research and development processes in pharmaceutical applications.
Molecule.one's top competitors include Insitro, HotSpot Therapeutics and Certara.
Molecule.one offers Custom Synthesis, SpaceM1, M1 RetroScore, Data Generation & Licensing, and MariaAI.
Molecule.one has 8 investors. Key investors include Atmos Ventures, AME Cloud Ventures, Cherubic Ventures, Possible Ventures, and Firlej Kastory.